Response Genetics, a company focused on the development and sale of molecular diagnostic tests for cancer, has announced that Thomas Stankovich has resigned from his position as chief financial officer (CFO) to pursue other interests. Stankovich will complete the filing of the company’s 2009 Annual Report on Form 10-K and has agreed to be available beyond his resignation date to assist in the transition of his role.
The company has commenced a search for a new CFO. In the interim, Eric Alcorn, vice president of finance and administration, will assume Stankovich’s responsibilities. Alcorn has been with the company since its inception.
Stankovich joined Response Genetics in November 2006. He has been responsible for management of the company’s finance functions, strategic planning and administrative services.
The annual BNP Paribas Cash Management University kicked off on Thursday morning with treasury professionals congregating in Paris from across Europe.
APIs may be a solution to MT940 challenges, says Karen Fagan, treasury operation manager, for British television company, ITV.
Kicking off the first day of the Singapore Fintech Festival, issues with cryptocurrencies were addressed by MIT media labs director, Joi Ito, and panels of technology leaders discussed how they’re using data analytics.
Sibos 2017 day two highlights: Brexit and banking, and why ‘data is the new oil’ in financial services
How nation first politics can impact global financial organisations It’s clear that data and regulation are the two key topics that are ... read more